aid: caidya
name: Caidya
description: 'Caidya is a full-service, global clinical research organization (CRO)
  formed from the April 2021 merger of dMed and Clinipace, rebranded to Caidya in October
  2022. It runs clinical development programs end to end — pre-IND and regulatory strategy,
  early phase, Phase II/III delivery, study start-up, trial feasibility, clinical operations,
  risk-based quality management, medical monitoring, clinical data management, biometrics,
  medical writing, pharmacovigilance, quality assurance and post-marketing surveillance
  — across oncology and hematology, cardiovascular-metabolic, rare disease, pediatrics,
  gastroenterology, nephrology, dermatology, ophthalmology, cell and gene therapy, neurology,
  immunology and infectious disease. The company took a $165M strategic growth investment
  from Rubicon Founders and announced a strategic combination with Simbec-Orion. Caidya
  is a clinical services provider rather than a software vendor: it integrates with sponsor-preferred
  EDC, eCOA, IRT, CTMS, eTMF and safety platforms rather than publishing a developer program
  or a public API of its own.'
image: https://www.caidya.com/wp-content/uploads/2026/06/og-image.png
url: https://raw.githubusercontent.com/api-evangelist/caidya/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.23'
created: '2026-08-08'
modified: '2026-08-08'
tags:
- Company
- Clinical Research
- Contract Research Organization
- Healthcare
- Life Sciences
- Pharmaceuticals
- Clinical Trials
- Clinical Data Management
- Pharmacovigilance
- Regulatory Affairs
- Biometrics
- Oncology
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/caidya-domain-security.yml
- type: Website
  url: https://www.caidya.com/
- type: Blog
  url: https://www.caidya.com/blog/
- type: News
  url: https://www.caidya.com/news/
- type: Support
  url: https://www.caidya.com/contact/
- type: PrivacyPolicy
  url: https://www.caidya.com/privacy-notices/
- type: TermsOfService
  url: https://www.caidya.com/disclaimer/
- type: LLMsTxt
  url: llms/caidya-llms.txt
- type: Conformance
  url: conformance/caidya-conformance.yml
- type: Compliance
  url: https://www.caidya.com/privacy-notices/
- type: SecondaryMarket
  url: https://www.hiive.com/securities/caidya-stock
x-enrichment:
  date: '2026-08-08'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: no-developer-program
  detail: >-
    Caidya is a clinical research organization that explicitly positions itself as an
    integrator of the sponsor's preferred EDC, eCOA, IRT, CTMS, eTMF and safety platforms
    rather than a publisher of its own — there is no developer portal, no api./developer.
    subdomain (both NXDOMAIN), and the only machine-readable file on the whole estate is a
    Yoast-generated marketing llms.txt.
  evidence:
  - url: https://www.caidya.com/llms.txt
    status: 200
  - url: https://www.caidya.com/openapi.json
    status: 404
  - url: https://www.caidya.com/.well-known/agent-card.json
    status: 404
  - url: https://www.caidya.com/.well-known/security.txt
    status: 404
  - url: https://www.caidya.com/about/clinical-technology-ecosystem/
    status: 200
  checked: '2026-08-08'